Extracellular MMP-9-Based Assessment of Ocular Surface Inflammation in Patients with Primary Open-Angle Glaucoma

Table 1

Summary of demographic characteristics and BCVA by study group.

	Preservative-free treatment (tafluprost) ()	BAK-containing treatment (latanoprost) ()	Untreated (control) ()	Total ()
Age
Mean ± SD	67.6 ± 7.8	67.1 ± 8.7	61.2 ± 11.9	65.3 ± 10.00
Range	50–90	50–78	31–81	31–90
% Females	73.3	86.7	80	80
BCVA, right eye
Mean ± SD	0.85 ± 0.19	0.81 ± 0.25	0.90 ± 0.20	0.85 ± 0.21
BCVA, left eye
Mean ± SD	0.84 ± 0.23	0.80 ± 0.19	0.90 ± 0.15	0.85 ± 0.20

SD, standard deviation.